Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

被引:44
|
作者
Valbuena, Alberto
Lopez-Sanchez, Inmaculada
Vega, Francisco M.
Sevilla, Ana
Sanz-Garcia, Marta
Blanco, Sandra
Lazo, Pedro A.
机构
[1] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain
[2] Univ Salamanca, CSIC, Ctr Invest Canc, Programa Oncol Translac, E-37007 Salamanca, Spain
关键词
VRK1; antibody; epitopes; immunohistochemistry; subcellular localization;
D O I
10.1016/j.abb.2007.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human VRK1 is a new ser-thr kinase expressed in many cell types. VRK1 is a regulator of p53 and other transcription factors related with cellular responses to stress. The human VRK1 protein has a dominant epitope located in its C-terminal region, between residues 333 and 396, which is detected by different antibodies. All the antibodies detect the same protein in immunoblots and immunoprecipitations. But the antibodies have a different reactivity when a single aminoacid substitution in T355, mimicking phosphorylation, is introduced next to the nuclear localization signal. These differences in reactivity permit the identification of different intracellular subpopulations. Most of the intracellular VRK1 protein is nuclear, but in some cells it is also detected in the cytosol, depending on the type of tissue. These different locations are detected by immunohistochemistry of human biopsies and immunofluorescence of cell lines. Some antibodies identify a subpopulation within the vesicular system, particularly in the Golgi apparatus. The different reactivity of the VRK1 protein indicates that this protein has a subcellular localization that can be regulated, thus adding an additional level of regulatory complexity to the VRK1 protein. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [21] VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
    Elena Martín-Doncel
    Ana M. Rojas
    Lara Cantarero
    Pedro A. Lazo
    Scientific Reports, 9
  • [22] DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
    Carrion-Marchante, Rebeca
    Frezza, Valerio
    Salgado-Figueroa, Ana
    Perez-Morgado, M. Isabel
    Martin, M. Elena
    Gonzalez, Victor M.
    PHARMACEUTICALS, 2021, 14 (05)
  • [23] VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
    Martin-Doncel, Elena
    Rojas, Ana M.
    Cantarero, Lara
    Lazo, Pedro A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1
    Barcia, R
    López-Borges, S
    Vega, FM
    Lazo, PA
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 399 (01) : 1 - 5
  • [25] p53 stabilization and accumulation induced by human vaccinia-related kinase 1
    Vega, FM
    Sevilla, A
    Lazo, PA
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (23) : 10366 - 10380
  • [26] Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε
    Gama, Fernando H. de Souza
    Dutra, Luiz A.
    Hawgood, Michael
    dos Reis, Caio Vinicius
    Serafim, Ricardo A. M.
    Ferreira Jr, Marcos A.
    Teodoro, Bruno V. M.
    Takarada, JessicaEmi
    Santiago, Andre S.
    Balourdas, Dimitrios-Ilias
    Nilsson, Ann-Sofie
    Urien, Bruno
    Almeida, Vitor M.
    Gileadi, Carina
    Ramos, Priscila Z.
    Salmazo, Anita
    Vasconcelos, Stanley N. S.
    Cunha, Micael R.
    Mueller, Susanne
    Knapp, Stefan
    Massirer, Katlin B.
    Elkins, Jonathan M.
    Gileadi, Opher
    Mascarello, Alessandra
    Lemmens, Bennie B. L. G.
    Guimaraes, Cristiano R. W.
    Azevedo, Hatylas
    Counago, Rafael M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 8609 - 8629
  • [27] Defective folliculogenesis in female mice lacking Vaccinia-related kinase 1
    Kim, Jinkyung
    Choi, Yoon Ha
    Chang, Soeun
    Kim, Kyong-Tai
    Je, Jung Ho
    SCIENTIFIC REPORTS, 2012, 2
  • [28] Defective folliculogenesis in female mice lacking Vaccinia-related kinase 1
    Jinkyung Kim
    Yoon Ha Choi
    Soeun Chang
    Kyong-Tai Kim
    Jung Ho Je
    Scientific Reports, 2
  • [29] Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase-2
    Vazquez-Cedeira, Marta
    Lazo, Pedro A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (51) : 42739 - 42750
  • [30] Vaccinia-related kinase 1 is required for early uterine development in Caenorhabditis elegans
    Dobrzynska, Agnieszka
    Askjaer, Peter
    DEVELOPMENTAL BIOLOGY, 2016, 411 (02) : 246 - 256